198 related articles for article (PubMed ID: 29335200)
1. Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors.
Lu D; Liu J; Zhang Y; Liu F; Zeng L; Peng R; Yang L; Ying H; Tang W; Chen W; Zuo J; Tong X; Liu T; Hu Y
Eur J Med Chem; 2018 Feb; 145():328-337. PubMed ID: 29335200
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents.
Lee JC; Tseng CK; Lin CK; Tseng CH
Eur J Med Chem; 2017 Dec; 141():282-292. PubMed ID: 29031073
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents.
Lin C; Yu J; Hussain M; Zhou Y; Duan A; Pan W; Yuan J; Zhang J
Antiviral Res; 2018 Jan; 149():95-105. PubMed ID: 29129706
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors.
Bardiot D; Koukni M; Smets W; Carlens G; McNaughton M; Kaptein S; Dallmeier K; Chaltin P; Neyts J; Marchand A
J Med Chem; 2018 Sep; 61(18):8390-8401. PubMed ID: 30149709
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 3-Arylquinoxaline Derivatives as Potential Anti-Dengue Virus Agents.
Tseng CH; Han CR; Tang KW
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561542
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
[TBL] [Abstract][Full Text] [Related]
7. Discovery and optimization of 2,4-diaminoquinazoline derivatives as a new class of potent dengue virus inhibitors.
Chao B; Tong XK; Tang W; Li DW; He PL; Garcia JM; Zeng LM; Gao AH; Yang L; Li J; Nan FJ; Jacobs M; Altmeyer R; Zuo JP; Hu YH
J Med Chem; 2012 Apr; 55(7):3135-43. PubMed ID: 22448770
[TBL] [Abstract][Full Text] [Related]
8. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
10. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antiproliferative and anti-dengue virus evaluations of 2-aroyl-3-arylquinoline derivatives.
Tseng CH; Lin CK; Chen YL; Hsu CY; Wu HN; Tseng CK; Lee JC
Eur J Med Chem; 2014 May; 79():66-76. PubMed ID: 24727241
[TBL] [Abstract][Full Text] [Related]
12. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hit.
Kounde CS; Yeo HQ; Wang QY; Wan KF; Dong H; Karuna R; Dix I; Wagner T; Zou B; Simon O; Bonamy GMC; Yeung BKS; Yokokawa F
Bioorg Med Chem Lett; 2017 Mar; 27(6):1385-1389. PubMed ID: 28216045
[TBL] [Abstract][Full Text] [Related]
14. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
15. Optimization of a fragment linking hit toward Dengue and Zika virus NS5 methyltransferases inhibitors.
Hernandez J; Hoffer L; Coutard B; Querat G; Roche P; Morelli X; Decroly E; Barral K
Eur J Med Chem; 2019 Jan; 161():323-333. PubMed ID: 30368131
[TBL] [Abstract][Full Text] [Related]
16. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection.
Yu W; Gill T; Wang L; Du Y; Ye H; Qu X; Guo JT; Cuconati A; Zhao K; Block TM; Xu X; Chang J
J Med Chem; 2012 Jul; 55(13):6061-75. PubMed ID: 22712544
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral evaluation of cytisine derivatives against dengue virus types 1 and 2.
Tsypysheva IP; Lai HC; Kiu YT; Koval'skaya AV; Tsypyshev DO; Huang SH; Lin CW
Bioorg Med Chem Lett; 2021 Dec; 54():128437. PubMed ID: 34737087
[TBL] [Abstract][Full Text] [Related]
19. Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines.
Saul S; Pu SY; Zuercher WJ; Einav S; Asquith CRM
Bioorg Med Chem Lett; 2020 Aug; 30(16):127284. PubMed ID: 32631507
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
